576 related articles for article (PubMed ID: 21945184)
21. Preparation of core cross-linked PCL-PEG-PCL micelles for doxorubicin delivery in vitro.
Zhang J; Men K; Gu Y; Wang X; Gou M; Guo G; Luo F; Qian Z
J Nanosci Nanotechnol; 2011 Jun; 11(6):5054-61. PubMed ID: 21770143
[TBL] [Abstract][Full Text] [Related]
22. Reversal of multidrug resistance by methoxypolyethylene glycol-block-polycaprolactone diblock copolymers through the inhibition of P-glycoprotein function.
Elamanchili P; McEachern C; Burt H
J Pharm Sci; 2009 Mar; 98(3):945-58. PubMed ID: 18623213
[TBL] [Abstract][Full Text] [Related]
23. Novel polymer micelle mediated co-delivery of doxorubicin and P-glycoprotein siRNA for reversal of multidrug resistance and synergistic tumor therapy.
Zhang CG; Zhu WJ; Liu Y; Yuan ZQ; Yang SD; Chen WL; Li JZ; Zhou XF; Liu C; Zhang XN
Sci Rep; 2016 Mar; 6():23859. PubMed ID: 27030638
[TBL] [Abstract][Full Text] [Related]
24. Enhanced effect of pH-sensitive mixed copolymer micelles for overcoming multidrug resistance of doxorubicin.
Qiu L; Qiao M; Chen Q; Tian C; Long M; Wang M; Li Z; Hu W; Li G; Cheng L; Cheng L; Hu H; Zhao X; Chen D
Biomaterials; 2014 Dec; 35(37):9877-9887. PubMed ID: 25201738
[TBL] [Abstract][Full Text] [Related]
25. Poly(styrene-alt-maleic anhydride)-based diblock copolymer micelles exhibit versatile hydrophobic drug loading, drug-dependent release, and internalization by multidrug resistant ovarian cancer cells.
Baranello MP; Bauer L; Benoit DS
Biomacromolecules; 2014 Jul; 15(7):2629-41. PubMed ID: 24955779
[TBL] [Abstract][Full Text] [Related]
26. Improved antitumor activity and reduced myocardial toxicity of doxorubicin encapsulated in MPEG-PCL nanoparticles.
Sun C; Zhou L; Gou M; Shi S; Li T; Lang J
Oncol Rep; 2016 Jun; 35(6):3600-6. PubMed ID: 27109195
[TBL] [Abstract][Full Text] [Related]
27. Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles.
Wu Y; Zhang Y; Zhang W; Sun C; Wu J; Tang J
Colloids Surf B Biointerfaces; 2016 Feb; 138():60-9. PubMed ID: 26655793
[TBL] [Abstract][Full Text] [Related]
28. Doxorubicin derivative loaded acetal-PEG-PCCL micelles for overcoming multidrug resistance in MCF-7/ADR cells.
Zhong XC; Xu WH; Wang ZT; Guo WW; Chen JJ; Guo NN; Wang TT; Lin MT; Zhang ZT; Lu YY; Yang QY; Han M; Xu DH; Gao JQ
Drug Dev Ind Pharm; 2019 Sep; 45(9):1556-1564. PubMed ID: 31271317
[No Abstract] [Full Text] [Related]
29. PEG-PE/clay composite carriers for doxorubicin: Effect of composite structure on release, cell interaction and cytotoxicity.
Kohay H; Sarisozen C; Sawant R; Jhaveri A; Torchilin VP; Mishael YG
Acta Biomater; 2017 Jun; 55():443-454. PubMed ID: 28400314
[TBL] [Abstract][Full Text] [Related]
30. Preparation, characterization and application of star-shaped PCL/PEG micelles for the delivery of doxorubicin in the treatment of colon cancer.
Gao X; Wang B; Wei X; Rao W; Ai F; Zhao F; Men K; Yang B; Liu X; Huang M; Gou M; Qian Z; Huang N; Wei Y
Int J Nanomedicine; 2013; 8():971-82. PubMed ID: 23493403
[TBL] [Abstract][Full Text] [Related]
31. Improving physicochemical properties and doxorubicin cytotoxicity of novel polymeric micelles by poly(ε-caprolactone) segments.
Qiu L; Zhang L; Zheng C; Wang R
J Pharm Sci; 2011 Jun; 100(6):2430-42. PubMed ID: 21491452
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, characterization, and property of biodegradable PEG-PCL-PLA terpolymers with miktoarm star and triblock architectures as drug carriers.
Zhang Y; Luo S; Liang Y; Zhang H; Peng X; He B; Li S
J Biomater Appl; 2018 Mar; 32(8):1139-1152. PubMed ID: 29298551
[TBL] [Abstract][Full Text] [Related]
33. Collagenase IV and clusterin-modified polycaprolactone-polyethylene glycol nanoparticles for penetrating dense tumor tissues.
Huang HY; Chen LQ; Sun W; Du HH; Dong S; Ahmed AMQ; Cao D; Cui JH; Zhang Y; Cao QR
Theranostics; 2021; 11(2):906-924. PubMed ID: 33391512
[No Abstract] [Full Text] [Related]
34. Targeting P-Glycoprotein: Nelfinavir Reverses Adriamycin Resistance in K562/ADR Cells.
Liu W; Meng Q; Sun Y; Wang C; Huo X; Liu Z; Sun P; Sun H; Ma X; Liu K
Cell Physiol Biochem; 2018; 51(4):1616-1631. PubMed ID: 30497065
[TBL] [Abstract][Full Text] [Related]
35. mPEG-b-PCL/TPGS mixed micelles for delivery of resveratrol in overcoming resistant breast cancer.
Wang S; Chen R; Morott J; Repka MA; Wang Y; Chen M
Expert Opin Drug Deliv; 2015 Mar; 12(3):361-73. PubMed ID: 25392124
[TBL] [Abstract][Full Text] [Related]
36. Mitochondria and Nucleus Dual Delivery System To Overcome DOX Resistance.
Cui H; Huan ML; Ye WL; Liu DZ; Teng ZH; Mei QB; Zhou SY
Mol Pharm; 2017 Mar; 14(3):746-756. PubMed ID: 28146635
[TBL] [Abstract][Full Text] [Related]
37. Pluronic-based functional polymeric mixed micelles for co-delivery of doxorubicin and paclitaxel to multidrug resistant tumor.
Chen Y; Zhang W; Huang Y; Gao F; Sha X; Fang X
Int J Pharm; 2015 Jul; 488(1-2):44-58. PubMed ID: 25899286
[TBL] [Abstract][Full Text] [Related]
38. Ligand-directed reduction-sensitive shell-sheddable biodegradable micelles actively deliver doxorubicin into the nuclei of target cancer cells.
Zhong Y; Yang W; Sun H; Cheng R; Meng F; Deng C; Zhong Z
Biomacromolecules; 2013 Oct; 14(10):3723-30. PubMed ID: 23998942
[TBL] [Abstract][Full Text] [Related]
39. Amphiphilic Copolymeric Micelles for Doxorubicin and Curcumin Co-Delivery to Reverse Multidrug Resistance in Breast Cancer.
Lv L; Qiu K; Yu X; Chen C; Qin F; Shi Y; Ou J; Zhang T; Zhu H; Wu J; Liu C; Li G
J Biomed Nanotechnol; 2016 May; 12(5):973-85. PubMed ID: 27305819
[TBL] [Abstract][Full Text] [Related]
40. Doxorubicin-loaded polymeric micelle overcomes multidrug resistance of cancer by double-targeting folate receptor and early endosomal pH.
Kim D; Lee ES; Oh KT; Gao ZG; Bae YH
Small; 2008 Nov; 4(11):2043-50. PubMed ID: 18949788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
